CAPLACIZUMAB-YHDP vs CAPMATINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CAPLACIZUMAB-YHDP vs CAPMATINIB: Safety Overview
| Metric | CAPLACIZUMAB-YHDP | CAPMATINIB |
|---|---|---|
| Total FAERS Reports | 1,397 | 2,301 |
| Deaths Reported | 59 | 583 |
| Death Rate | 4.2% | 25.3% |
| Hospitalizations | 270 | 388 |
| Average Patient Age | 46.1 yrs | 71.9 yrs |
| % Female Patients | 70.4% | 53.9% |
| FDA Approval Date | N/A | May 6, 2020 |
| Manufacturer | N/A | Novartis Pharmaceuticals Corporation |
| Route | N/A | ORAL |
| Marketing Status | Prescription | Prescription |